Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients

Fig. 1

Characterization of the MBDA CVD risk score in the validation dataset (N = 10,275). a Relationship between MBDA-based CVD risk score and predicted 3-year risk of a CVD event, with 95% confidence interval. b Distribution of predicted 3-year risks. Dotted lines, horizontal in a and vertical in b, indicate thresholds at 1.3%, 1.8%, and 5.2% separating the categories of low, borderline, intermediate, and high risk, which contained 9.4%, 10.2%, 52.2%, and 28.2% of patients, respectively. CVD event is myocardial infarction, stroke, or CVD death. CVD cardiovascular disease, MBDA multi-biomarker disease activity

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us